CASI Pharmaceuticals
CASI
#8753
Rank
NZ$0.13 B
Marketcap
$8.91
Share price
-7.55%
Change (1 day)
108.57%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2024 (TTM): -NZ$44.27 M

According to CASI Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -NZ$43.51 M. In 2023 the company made an earning of -NZ$42.63 M an increase over its 2022 earnings that were of -NZ$60.51 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$44.27 M3.85%
2023 -NZ$42.63 M-29.55%
2022 -NZ$60.51 M4.43%
2021 -NZ$57.94 M-24.56%
2020 -NZ$76.8 M4.74%
2019 -NZ$73.33 M65.13%
2018 -NZ$44.41 M155.07%
2017 -NZ$17.41 M13.93%
2016 -NZ$15.29 M31.18%
2015 -NZ$11.65 M-72.5%
2014 -NZ$42.36 M356.62%
2013 -NZ$9.28 M-60.55%
2012 -NZ$23.52 M218.41%
2011 -NZ$7.39 M0.74%
2010 -NZ$7.33 M-32.54%
2009 -NZ$10.87 M-66.98%
2008 -NZ$32.91 M-14.22%
2007 -NZ$38.36 M7.04%
2006 -NZ$35.84 M27.95%
2005 -NZ$28.01 M4.51%
2004 -NZ$26.8 M-15.84%
2003 -NZ$31.85 M-55.29%
2002 -NZ$71.23 M-34.05%
2001 -NZ$0.11 B31.73%
2000 -NZ$81.98 M31.56%
1999 -NZ$62.32 M145.56%
1998 -NZ$25.38 M76.4%
1997 -NZ$14.39 M36.92%
1996 -NZ$10.51 M